Olivia Osborn

Company: Terns Pharmaceuticals

Job title: Senior Director Biology

Seminars:

Innovative Approaches to Muscle Preservation During Weight Reduction: A Focus on Combination Therapies 12:00 pm

Exploring thyroid hormone receptor-beta (THRβ) agonist in combination with GLP-1R Examining the prevention of the metabolic adaptation that typically reduces energy expenditure during weight loss, resulting in greater overall weight loss and preservation of lean mass Detailing the preclinical findings that combination of TERN-501 plus GLP-1R agonism led to greater weight loss and increased fat…Read more

day: Conference Day One